Following a U.S. Food and Drug Administration (FDA) inspection, generic drug manufacturer Actavis Totowa LLC has announced a voluntary recall of all drug products manufactured at its Little Falls, New Jersey facility. The FDA inspection uncovered procedures that did not meet criteria for good manufacturing measures as established by the FDA and Actavis.
The recall affects products sold at pharmacies and in retail stores and was not prompted by product complaints or health risks. Because of this, patients who are taking the recalled medications are encouraged to continue to do so, since sudden discontinuation of the drugs could put patients in danger.
Patients can contact their doctors or a pharmacist if they wish to receive replacement medications or prescriptions.